ELITE PHARMACEUTICALS INC /NV/ Annual General and Administrative Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual General and Administrative Expense history and growth rate from 2010 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ General and Administrative Expense for the quarter ending September 30, 2024 was $2.27M, a 48.3% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ General and Administrative Expense for the twelve months ending September 30, 2024 was $8.19M, a 51.5% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual General and Administrative Expense for 2023 was $7.15M, a 39.5% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual General and Administrative Expense for 2022 was $5.12M, a 14.7% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual General and Administrative Expense for 2021 was $4.46M, a 34.3% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.15M +$2.02M +39.5% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $5.12M +$658K +14.7% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 $4.46M +$1.14M +34.3% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 $3.32M -$26.8K -0.8% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 $3.35M +$266K +8.64% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $3.08M +$751K +32.2% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 $2.33M +$249K +12% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 $2.08M -$820K -28.2% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 $2.9M -$936 -0.03% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 $2.9M +$798K +37.9% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 $2.11M +$592K +39.1% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 $1.51M +$103K +7.32% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 $1.41M +$534K +61% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
2010 $876K Apr 1, 2010 Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.